[go: up one dir, main page]

AU2002239279A1 - Oral nanosphere delivery - Google Patents

Oral nanosphere delivery

Info

Publication number
AU2002239279A1
AU2002239279A1 AU2002239279A AU3927902A AU2002239279A1 AU 2002239279 A1 AU2002239279 A1 AU 2002239279A1 AU 2002239279 A AU2002239279 A AU 2002239279A AU 3927902 A AU3927902 A AU 3927902A AU 2002239279 A1 AU2002239279 A1 AU 2002239279A1
Authority
AU
Australia
Prior art keywords
oral
nanosphere delivery
nanosphere
delivery
oral nanosphere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239279A
Inventor
James M Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PR Pharmaceuticals Inc
Original Assignee
PR Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PR Pharmaceuticals Inc filed Critical PR Pharmaceuticals Inc
Publication of AU2002239279A1 publication Critical patent/AU2002239279A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002239279A 2000-11-20 2001-11-20 Oral nanosphere delivery Abandoned AU2002239279A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25207000P 2000-11-20 2000-11-20
US60252070 2000-11-20
US60/252,070 2000-11-20
PCT/US2001/043299 WO2002041829A2 (en) 2000-11-20 2001-11-20 Oral nanosphere delivery

Publications (1)

Publication Number Publication Date
AU2002239279A1 true AU2002239279A1 (en) 2002-06-03

Family

ID=22954465

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239279A Abandoned AU2002239279A1 (en) 2000-11-20 2001-11-20 Oral nanosphere delivery

Country Status (3)

Country Link
AU (1) AU2002239279A1 (en)
CA (1) CA2429254A1 (en)
WO (1) WO2002041829A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706289B2 (en) 2000-10-31 2004-03-16 Pr Pharmaceuticals, Inc. Methods and compositions for enhanced delivery of bioactive molecules
CN101514223B (en) 2003-04-11 2017-03-01 安特里阿比奥有限公司 The preparation method of site-specific protein conjugates
EP1774971A1 (en) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Chitosan and heparin nanoparticles
US20070212386A1 (en) * 2006-03-08 2007-09-13 Sahajanand Medical Technologies Pvt. Ltd. Coatings for implantable medical devices
ES2310122B1 (en) * 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A NANOPARTICLES THAT INCLUDE A CYCLODEXTRINE AND A BIOLOGICALLY ACTIVE MOLECULA AND ITS APPLICATIONS.
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
NO2105129T3 (en) * 2008-03-24 2018-06-16
EP2153821A1 (en) * 2008-08-06 2010-02-17 BioAlliance Pharma Oral formulations of camptothecin derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent

Also Published As

Publication number Publication date
CA2429254A1 (en) 2002-05-30
WO2002041829A2 (en) 2002-05-30
WO2002041829A3 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
AU2002218250A1 (en) Medicament dispenser
AU2002223028A1 (en) Inhaler
AU2002242883A1 (en) Medicament dispenser
AU2002251238A1 (en) Medicament dispenser
AU2002358805A1 (en) Medicament dispenser
AU2002223562A1 (en) Medicament dispenser
AU2001272645A1 (en) Delivery device
AU2002352410A1 (en) Improved oral medicine dispenser
EP1151704A3 (en) Delivery box
AU2001259693A1 (en) Oral devices
AU2001275286A1 (en) Transdermal delivery
AU2001232020A1 (en) Floating drug delivery composition
AU2001290239A1 (en) Medicinal composition
AU2001296622A1 (en) Oral devices
AU2001225164A1 (en) Compositions with enhanced oral bioavailability
AU2002221099A1 (en) Combination drugs
AU2002239279A1 (en) Oral nanosphere delivery
AU2001232244A1 (en) Drug comprising combination
AU4085201A (en) Pharmaceutical composition
AU2001282527A1 (en) Antiparkinsonism drugs
AU2001244854A1 (en) Local drug delivery
AU2001278788A1 (en) Oral composition
AU2002215902A1 (en) Medicament dispenser
AU3586401A (en) Pharmaceutical composition
AU2001278487A1 (en) Oral composition